Johnson County Clin-Trials
Johnson County Clin-Trials
Lenexa, Kansas, United States5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-10-09 | NCT06672055 | |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health | Filoviridae infectious disease, Infections, Marburg hemorrhagic fever, Mononegavirales infectious disease, RNA Virus Infections, monkey disease, non-human animal disease, non-human primate disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-23 | NCT07425821 | |
| A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-21 | NCT07565090 | |
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults | DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, infectious mononucleosis, leukocyte disorder, lymphatic system disorder, lymphoproliferative syndrome, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-06 | NCT05164094 | |
| A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine | Alphavirus infectious disease, Encephalitis, Arbovirus, Encephalitis, Viral, Encephalomyelitis, Equine, Infections, Mosquito-Borne Diseases, Neuroinflammatory Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, encephalomyelitis, infectious encephalitis, nervous system disorder, vector-borne disease, viral infection of central nervous system, viral infectious disease | Active, not recruiting | Phase 2 | 2025-10-01 | NCT06899802 |